Robert S. KING,Cynthia W. TUTHILL,Friedhelm BLOBEL
申请号:
US15641550
公开号:
US20180161399A1
申请日:
2017.07.05
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.